Parathyroidectomy rates among United States dialysis patients: 1990-1999.

PubWeight™: 2.37‹?› | Rank: Top 2%

🔗 View Article (PMID 14675061)

Published in Kidney Int on January 01, 2004

Authors

Bryan Kestenbaum1, Stephen L Seliger, Daniel L Gillen, Haimanot Wasse, Bessie Young, Donald J Sherrard, Noel S Weiss, Catherine O Stehman-Breen

Author Affiliations

1: University of Washington Department of Medicine, Division of Nephrology, Seattle, Washington 98195, USA. epware@earthlink.net

Articles citing this

Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis. Clin J Am Soc Nephrol (2014) 1.29

Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials. PLoS Med (2013) 1.01

Survival after parathyroidectomy in patients with end-stage renal disease and severe hyperparathyroidism. World J Surg (2007) 0.96

Postoperative hungry bone syndrome in patients with secondary hyperparathyroidism of renal origin. World J Surg (2012) 0.93

The surgical management of renal hyperparathyroidism. Eur Arch Otorhinolaryngol (2011) 0.91

The effect of parathyroidectomy on patient survival in secondary hyperparathyroidism. Nephrol Dial Transplant (2015) 0.90

Effect of cinacalcet availability and formulary listing on parathyroidectomy rate trends. BMC Nephrol (2013) 0.88

Development and treatment of tertiary hyperparathyroidism in patients with pseudohypoparathyroidism type 1B. J Clin Endocrinol Metab (2012) 0.87

Rates and Outcomes of Parathyroidectomy for Secondary Hyperparathyroidism in the United States. Clin J Am Soc Nephrol (2016) 0.84

Temporal trends and risk factors for parathyroidectomy in the Swedish dialysis and transplant population - a nationwide, population-based study 1991 - 2009. BMC Nephrol (2014) 0.84

Surgical and medical treatment of secondary hyperparathyroidism in patients on continuous dialysis. World J Surg (2009) 0.82

Incidence of and risk factors for hungry bone syndrome in 84 patients with secondary hyperparathyroidism. Int J Nephrol Renovasc Dis (2013) 0.81

Reduced Stroke Risk After Parathyroidectomy in End-Stage Renal Disease: A 13-Year Population-Based Cohort Study. Medicine (Baltimore) (2015) 0.78

Parathyroidectomy: Complex Decisions about a Complex Procedure. Clin J Am Soc Nephrol (2016) 0.76

Parathyroid ultrasonography and bone metabolic profile of patients on dialysis with hyperparathyroidism. World J Nephrol (2016) 0.75

Parathyroidectomy in ESRD. Kidney Int (2004) 0.75

Medical control of secondary hyperparathyroidism: we're not there yet. Kidney Int (2004) 0.75

Parathyroidectomy Associates with Reduced Mortality in Taiwanese Dialysis Patients with Hyperparathyroidism: Evidence for the Controversy of Current Guidelines. Sci Rep (2016) 0.75

Articles by these authors

Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med (2005) 15.30

Collaborative care for patients with depression and chronic illnesses. N Engl J Med (2010) 8.92

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA (2003) 7.42

Combined angiotensin inhibition for the treatment of diabetic nephropathy. N Engl J Med (2013) 7.29

Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol (2004) 6.59

Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med (2006) 6.58

Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care (2004) 6.09

Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev Res (Phila) (2008) 5.82

Trends in bariatric surgical procedures. JAMA (2005) 5.67

Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA (2010) 5.37

Potential for conflict of interest in the evaluation of suspected adverse drug reactions: use of cerivastatin and risk of rhabdomyolysis. JAMA (2004) 4.71

Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA (2011) 4.70

The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care (2005) 4.65

Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med (2005) 4.57

Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas. Gastroenterology (2013) 4.43

Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol (2005) 4.04

Outcomes of planned home births in Washington State: 1989-1996. Obstet Gynecol (2002) 3.99

Predictive value of symptoms for early detection of ovarian cancer. J Natl Cancer Inst (2010) 3.42

Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care (2004) 3.40

Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology (2002) 3.28

Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet (2008) 3.23

Hormone replacement therapy in relation to breast cancer. JAMA (2002) 3.14

Efficacy of breast cancer screening in the community according to risk level. J Natl Cancer Inst (2005) 3.06

Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA (2003) 3.04

The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection. Hepatology (2013) 2.98

Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol (2005) 2.92

Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury. Am J Kidney Dis (2002) 2.89

Randomized trial of light versus deep sedation on mental health after critical illness. Crit Care Med (2009) 2.83

Risk of HIV-1 in rural Kenya: a comparison of circumcised and uncircumcised men. Epidemiology (2004) 2.82

Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study. J Am Soc Nephrol (2004) 2.82

Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care (2008) 2.76

Hypericum perforatum (St John's wort) for attention-deficit/hyperactivity disorder in children and adolescents: a randomized controlled trial. JAMA (2008) 2.76

The frequency of hyperkalemia and its significance in chronic kidney disease. Arch Intern Med (2009) 2.76

A comparison between audio computer-assisted self-interviews and clinician interviews for obtaining the sexual history. Sex Transm Dis (2004) 2.62

Circulating biomarkers of inflammation, antioxidant activity, and platelet activation are associated with primary combustion aerosols in subjects with coronary artery disease. Environ Health Perspect (2008) 2.59

Menopausal hormone therapy and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev (2007) 2.55

Association of oral calcitriol with improved survival in nondialyzed CKD. J Am Soc Nephrol (2008) 2.47

Neighborhood poverty and racial disparities in kidney transplant waitlisting. J Am Soc Nephrol (2009) 2.45

25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis (2007) 2.40

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA (2002) 2.37

Elevated risk of stroke among patients with end-stage renal disease. Kidney Int (2003) 2.35

Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med (2008) 2.33

Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing. J Am Coll Cardiol (2010) 2.32

Recent trials in hypertension: compelling science or commercial speech? JAMA (2006) 2.30

A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury. Crit Care Med (2011) 2.27

Management guided by brain tissue oxygen monitoring and outcome following severe traumatic brain injury. J Neurosurg (2009) 2.21

Treatment center and geographic variability in pre-ESRD care associate with increased mortality. J Am Soc Nephrol (2009) 2.21

Male circumcision in Siaya and Bondo Districts, Kenya: prospective cohort study to assess behavioral disinhibition following circumcision. J Acquir Immune Defic Syndr (2007) 2.21

Incidence of suicide in persons with cancer. J Clin Oncol (2008) 2.21

Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Cancer (2003) 2.20

Effect of acute lung injury and acute respiratory distress syndrome on outcome in critically ill trauma patients. Crit Care Med (2004) 2.20

Dietary phosphorus is associated with greater left ventricular mass. Kidney Int (2013) 2.19

Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol (2008) 2.18

Cost-effectiveness of a multicondition collaborative care intervention: a randomized controlled trial. Arch Gen Psychiatry (2012) 2.16

Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis. Am J Physiol Renal Physiol (2007) 2.15

Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med (2013) 2.15

The relationship between dialysis performance measures: adequacy and anemia management. Am J Kidney Dis (2007) 2.09

Tradeoffs between accuracy measures for electronic health care data algorithms. J Clin Epidemiol (2011) 2.06

Air pollution exposures and circulating biomarkers of effect in a susceptible population: clues to potential causal component mixtures and mechanisms. Environ Health Perspect (2009) 2.06

Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01

Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus. Arch Intern Med (2008) 2.01

Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol (2009) 2.01

Reporting participation in case-control studies. Epidemiology (2002) 1.99

Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl. Kidney Int (2005) 1.96

Depression and diabetes symptom burden. Gen Hosp Psychiatry (2004) 1.96

Iron deficiency and gastrointestinal malignancy: a population-based cohort study. Am J Med (2002) 1.96

Limitations of basing screening policies on screening trials: The US Preventive Services Task Force and Prostate Cancer Screening. Med Care (2013) 1.88

Cystatin C and subclinical brain infarction. J Am Soc Nephrol (2005) 1.88

Functional outcomes of multi-condition collaborative care and successful ageing: results of randomised trial. BMJ (2011) 1.85

Risk of hip fracture among dialysis and renal transplant recipients. JAMA (2002) 1.81

The prevalence of knee pain and symptomatic knee osteoarthritis among veteran traumatic amputees and nonamputees. Arch Phys Med Rehabil (2005) 1.81

Environment or host?: A case-control study of risk factors for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med (2012) 1.78

Incidence of primary urethral carcinoma in the United States. Urology (2006) 1.78

Trends in treatment of advanced epithelial ovarian cancer in the Medicare population. Gynecol Oncol (2011) 1.77

Effects of enhanced depression treatment on diabetes self-care. Ann Fam Med (2006) 1.76

Association between serum uric acid level and chronic liver disease in the United States. Hepatology (2010) 1.76

The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval. Gastroenterology (2004) 1.74

Physical activity, change in biomarkers of myocardial stress and injury, and subsequent heart failure risk in older adults. J Am Coll Cardiol (2012) 1.74

First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl. Kidney Int (2005) 1.74

A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall's plaque. BJU Int (2008) 1.72

New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J Clin Epidemiol (2009) 1.72

Chronic kidney disease, creatinine and cognitive functioning. Nephrol Dial Transplant (2009) 1.71

Functional outcomes in pediatric severe sepsis: further analysis of the researching severe sepsis and organ dysfunction in children: a global perspective trial. Pediatr Crit Care Med (2013) 1.70

Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. JAMA (2004) 1.70

A refill adherence algorithm for multiple short intervals to estimate refill compliance (ReComp). Med Care (2007) 1.69

Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients. Am J Kidney Dis (2002) 1.69

Associations of primary and secondary organic aerosols with airway and systemic inflammation in an elderly panel cohort. Epidemiology (2010) 1.68

Inflammation and endometrial cancer: a hypothesis. Cancer Epidemiol Biomarkers Prev (2005) 1.68

Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy. Am J Epidemiol (2012) 1.68

Cardiac risk factors in patients with diabetes mellitus and major depression. J Gen Intern Med (2004) 1.67

Frequency of swing-segment stenosis in referred dialysis patients with angiographically documented lesions. Am J Kidney Dis (2008) 1.66

Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States. Hepatology (2006) 1.65

Long-term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancer. Am J Obstet Gynecol (2007) 1.65